Chen YC, Chang TK, Su WC, Yeh YS, et al. Impact on survival benefits of asymptomatic primary tumor resection after bevacizumab plus FOLFIRI as first-line therapy for patients with metastatic colorectal cancer with synchronous unresectable metastasis. Int J Colorectal Dis 2024;39:171.
PMID: 39453531